Skip to main content

Table 2 Patients’ characteristics and dose of MSC injected

From: Intra-articular injection of expanded autologous bone marrow mesenchymal cells in moderate and severe knee osteoarthritis is safe: a phase I/II study

Variables Mean (range)
Age/years 50 (34–63)
Gender (F/M) 7/6
KOA stage (II/III) 5/8
Cell dose in 1st treatment (106) 30.8 (28–35)
Cell dose in 2nd treatment (106) 30.4 (26–33)
Time interval/days between treatments 92.3 (90–110)